Interplay between coronaviruses and nonsense-mediated mRNA decay pathway

冠状病毒与无义介导的 mRNA 衰减途径之间的相互作用

基本信息

  • 批准号:
    10358595
  • 负责人:
  • 金额:
    $ 30.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-03-11 至 2024-02-28
  • 项目状态:
    已结题

项目摘要

Coronaviruses (CoVs), which carry a large, single-stranded, positive-sense RNA genome, cause a variety of diseases in humans and domestic animals. Human CoVs (HCoVs) usually infect the respiratory tract and cause a range of symptoms varying from mild, such as the common cold, to more serious respiratory illnesses like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), caused by two highly pathogenic HCoVs, SARS-CoV and MERS-CoV. SARS-CoV caused a worldwide epidemic in 2002- 2003, resulting in more than 8,000 cases with an approximate mortality of 10%, while MERS-CoV emerged in Saudi Arabia in 2012 and has been disseminated into other countries in the Middle East, North Africa, Europe, and East Asia. HCoVs represent a major threat to public health and have the potential to cause a significant negative economic impact. Currently, there are no approved vaccines and therapeutic agents against HCoVs. The development of effective control measures against CoVs requires a comprehensive understanding of viral gene expression strategies and host-CoV interactions. A plethora of studies have focused on investigating CoV biology and have significantly contributed to our understanding of CoV replication mechanisms, including the structure-function analyses of viral RNA elements as well as the viral proteins that are involved in viral replication and assembly. However, there are still gaps in our knowledge of the post-transcriptional regulation of viral gene expression, as only a limited number of studies have addressed this area of CoV research. Particularly, very little is known about the cis-acting viral RNA elements and trans-acting host and viral factors that regulate CoV mRNA transcript stability. One newly emerging research area in virology is understanding interactions between viruses and host mRNA surveillance pathways that prevent generation/accumulation of unwanted gene products. We have demonstrated that CoV mRNAs are the targets of the nonsense-mediated mRNA decay (NMD) pathway, one of the host mRNA surveillance pathways, and that viral N protein protects CoV mRNAs from NMD. Our data suggest the importance of N-mediated NMD suppression for efficient virus replication. The present application will study the interplay between the NMD pathway and CoVs by testing the following hypotheses: UPF1, the principal orchestrator of NMD, binds to the 3’ UTR of CoV mRNAs having specific motifs, undergoes phosphorylation, and recruits SMG6, an endonuclease, leading to endonucleolytic RNA cleavage; N binds to the 3’ UTRs of NMD targets and prevents an NMD factor(s) from accessing these targets and/or N interacts with an NMD factor(s) and sequesters it away from the NMD pathway; and CoV mutants having an increased susceptibility to NMD, cannot replicate as efficiently as the parental viruses. The data obtained from these studies will provide mechanistic insights into NMD of CoV mRNAs and N-mediated NMD pathway suppression, and will reveal the feasibility of novel strategies for attenuating CoVs through increased susceptibility to the NMD pathway.
冠状病毒 (CoV) 携带大型单链正链 RNA 基因组,可引起多种疾病 人类和家畜疾病。人类冠状病毒(HCoV)通常感染呼吸道并 引起一系列症状,从普通感冒等轻微症状到更严重的呼吸道疾病 例如严重急性呼吸系统综合症(SARS)和中东呼吸系统综合症(MERS),由两种疾病引起 高致病性 HCoV、SARS-CoV 和 MERS-CoV。 2002年,SARS-CoV在全球范围内引发流行病 2003 年,导致 8,000 多例病例,死亡率约为 10%,而 MERS-CoV 出现在 2012年在沙特阿拉伯上市,并已传播到中东、北非、欧洲等其他国家, 和东亚。 HCoV 对公共健康构成重大威胁,并有可能造成严重后果 负面经济影响。目前,尚无针对 HCoV 的批准疫苗和治疗药物。 制定针对冠状病毒的有效控制措施需要全面了解病毒 基因表达策略和宿主-冠状病毒相互作用。大量研究都集中在调查冠状病毒 生物学,并为我们对冠状病毒复制机制的理解做出了重大贡献,包括 病毒RNA元件以及参与病毒感染的病毒蛋白的结构功能分析 复制和组装。然而,我们对转录后调控的认识仍然存在差距。 病毒基因表达的研究,因为只有有限数量的研究涉及冠状病毒研究的这一领域。 特别是,对于顺式作用病毒RNA元件和反式作用宿主和病毒因子知之甚少 调节 CoV mRNA 转录稳定性。病毒学的一个新兴研究领域是了解 病毒和宿主 mRNA 监视途径之间的相互作用,防止产生/积累 不需要的基因产物。我们已经证明 CoV mRNA 是无义介导的靶标 mRNA 衰减 (NMD) 途径是宿主 mRNA 监视途径之一,病毒 N 蛋白可保护 来自 NMD 的 CoV mRNA。我们的数据表明 N 介导的 NMD 抑制对于有效病毒的重要性 复制。本申请将通过测试 NMD 途径和 CoV 之间的相互作用来研究 以下假设:UPF1 是 NMD 的主要协调者,与具有以下特征的 CoV mRNA 的 3’UTR 结合 特定基序,经历磷酸化,并招募 SMG6(一种核酸内切酶),导致核酸内切 RNA 切割; N 与 NMD 目标的 3' UTR 结合,并阻止 NMD 因子访问这些目标 目标和/或 N 与 NMD 因子相互作用并将其隔离于 NMD 途径;和冠状病毒 对 NMD 敏感性增加的突变体不能像亲代病毒那样有效地复制。这 从这些研究中获得的数据将为 CoV mRNA 的 NMD 和 N 介导的机制提供见解 NMD 通路抑制,并将揭示通过以下方式减弱 CoV 的新策略的可行性 对 NMD 途径的敏感性增加。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shinji Makino其他文献

Shinji Makino的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shinji Makino', 18)}}的其他基金

Mechanism of viral RNP recognition by the envelope glycoprotein and its role in RNA segment packaging in Rift Valley Fever phlebovirus
裂谷热白蛉病毒包膜糖蛋白识别病毒RNP的机制及其在RNA片段包装中的作用
  • 批准号:
    10057583
  • 财政年份:
    2020
  • 资助金额:
    $ 30.92万
  • 项目类别:
Mechanism of viral RNP recognition by the envelope glycoprotein and its role in RNA segment packaging in Rift Valley Fever phlebovirus
裂谷热白蛉病毒包膜糖蛋白识别病毒RNP的机制及其在RNA片段包装中的作用
  • 批准号:
    10188412
  • 财政年份:
    2020
  • 资助金额:
    $ 30.92万
  • 项目类别:
Interplay between coronaviruses and nonsense-mediated mRNA decay pathway
冠状病毒与无义介导的 mRNA 衰减途径之间的相互作用
  • 批准号:
    10614383
  • 财政年份:
    2020
  • 资助金额:
    $ 30.92万
  • 项目类别:
Rational Development of a Novel Attenuated Rift Valley Fever Virus Vaccine
新型裂谷热病毒减毒疫苗的合理研制
  • 批准号:
    9386475
  • 财政年份:
    2017
  • 资助金额:
    $ 30.92万
  • 项目类别:
Development of Safer,Live Attenuated Rift Valley Fever Vaccines
开发更安全的裂谷热减毒活疫苗
  • 批准号:
    9091408
  • 财政年份:
    2015
  • 资助金额:
    $ 30.92万
  • 项目类别:
New Paradigm for Host and Viral Gene Regulation by MERS Coronavirus nsp1
MERS 冠状病毒 nsp1 宿主和病毒基因调控的新范式
  • 批准号:
    9189963
  • 财政年份:
    2015
  • 资助金额:
    $ 30.92万
  • 项目类别:
Development of a Novel Rift Valley Fever Virus Vaccine
新型裂谷热病毒疫苗的开发
  • 批准号:
    8604678
  • 财政年份:
    2013
  • 资助金额:
    $ 30.92万
  • 项目类别:
Development of a Novel Rift Valley Fever Virus Vaccine
新型裂谷热病毒疫苗的开发
  • 批准号:
    8509347
  • 财政年份:
    2013
  • 资助金额:
    $ 30.92万
  • 项目类别:
Analysis of Coronavirus-Host Cell Interactions
冠状病毒-宿主细胞相互作用分析
  • 批准号:
    8442842
  • 财政年份:
    2012
  • 资助金额:
    $ 30.92万
  • 项目类别:
Analysis of Coronavirus-Host Cell Interactions
冠状病毒-宿主细胞相互作用分析
  • 批准号:
    8888201
  • 财政年份:
    2012
  • 资助金额:
    $ 30.92万
  • 项目类别:

相似海外基金

Impact of alternative polyadenylation of 3'-untranslated regions in the PI3K/AKT cascade on microRNA
PI3K/AKT 级联中 3-非翻译区的替代多聚腺苷酸化对 microRNA 的影响
  • 批准号:
    573541-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 30.92万
  • 项目类别:
    University Undergraduate Student Research Awards
How do untranslated regions of cannabinoid receptor type 1 mRNA determine receptor subcellular localisation and function?
1 型大麻素受体 mRNA 的非翻译区如何决定受体亚细胞定位和功能?
  • 批准号:
    2744317
  • 财政年份:
    2022
  • 资助金额:
    $ 30.92万
  • 项目类别:
    Studentship
MICA:Synthetic untranslated regions for direct delivery of therapeutic mRNAs
MICA:用于直接递送治疗性 mRNA 的合成非翻译区
  • 批准号:
    MR/V010948/1
  • 财政年份:
    2021
  • 资助金额:
    $ 30.92万
  • 项目类别:
    Research Grant
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
  • 批准号:
    10019570
  • 财政年份:
    2019
  • 资助金额:
    $ 30.92万
  • 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
  • 批准号:
    10223370
  • 财政年份:
    2019
  • 资助金额:
    $ 30.92万
  • 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
  • 批准号:
    10455108
  • 财政年份:
    2019
  • 资助金额:
    $ 30.92万
  • 项目类别:
Synergistic microRNA-binding sites, and 3' untranslated regions: a dialogue of silence
协同的 microRNA 结合位点和 3 非翻译区:沉默的对话
  • 批准号:
    255762
  • 财政年份:
    2012
  • 资助金额:
    $ 30.92万
  • 项目类别:
    Operating Grants
Analysis of long untranslated regions in Nipah virus genome
尼帕病毒基因组长非翻译区分析
  • 批准号:
    20790351
  • 财政年份:
    2008
  • 资助金额:
    $ 30.92万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Search for mRNA elements involved in the compatibility between 5' untranslated regions and coding regions in chloroplast translation
寻找参与叶绿体翻译中 5 非翻译区和编码区之间兼容性的 mRNA 元件
  • 批准号:
    19370021
  • 财政年份:
    2007
  • 资助金额:
    $ 30.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Post-transcriptional Regulation of PPAR-g Expression by 5'-Untranslated Regions
5-非翻译区对 PPAR-g 表达的转录后调控
  • 批准号:
    7131841
  • 财政年份:
    2006
  • 资助金额:
    $ 30.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了